Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine

Clinical trial NCT04332627 · COMPLETED

Trial details

NCT number: NCT04332627
Sponsor: Seoul National University Bundang Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade Reversal Agent Sugammadex Neostigmine Quality of Recovery Laparoscopic Cholecystectomy

Start date: 2020-02-24
Primary completion: 2020-05-21
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.